Join Us for an Academy Breakfast Talk Sponsored by Tarsus.
You're invited to an exclusive Academy Breakfast Talk Session during Academy 2025 Boston, featuring a complimentary breakfast and a dynamic presentation from industry leaders.
Session Title: XDEMVY® (lotilaner ophthalmic solution) 0.25%: Appropriate Patient Types and Clinical Insights
Speakers: Mark Schaeffer, OD, FAAO
Session Overview: Join Tarsus for a breakfast session focused on XDEMVY® (lotilaner ophthalmic solution) 0.25%, the first and only FDA-approved treatment for Demodex blepharitis. Gain clinical insights into identifying appropriate patient types, hear practical tips for integrating treatment into practice, and explore how this therapy can improve patient care.
If you're interested in attending, please complete the form below to receive session updates and a day-of reminder. Space is limited and attendance is available on a first-come, first-served basis.
We look forward to seeing you there!